GERRESHEIMER AG

GXI
Delayed Quote. Delayed  - 07/01 11:38:17 am
57.95EUR -6.53%

Gerresheimer AG Executes on Its Growth Strategy in Emerging Markets Boosting Capacities in India

05/16/2022 | 05:18am
Gerresheimer has significantly ramped up its glass and plastic production capacities in India to satisfy its global pharma customer needs. A new modern plant to produce high quality plastic containers and closures was built at the Kosamba site, and glass production received a new and sustainable furnace technology. This is in line with the company's formula G growth strategy. By adding capacities in India, Gerresheimer executes on its growth strategy in Emerging Markets addressing the global mega trend for increasing health care access in these markets and the rising demand for vaccination. Being a leading partner for global pharma and healthcare customers, Gerresheimer already operates in India. The new production capabilities combine the company's know how and network in glass and plastic, offering solutions alongside the broad Gerresheimer portfolio. Gerresheimer follows a clear roadmap for further global capacity increases alongside its holistic capital allocation process. The capacity increase in India is part of Gerresheimer's investment program to sharpen the company's growth and return profile. Over the previous two years, the company invested a double digit million Euro amount into new furnaces in Kosamba with the latest glass melting technology. The new furnace is equipped with newest production machines also having most sensitive inspection equipment following the Gerresheimer molded glass production standards. With this technology, the company will substantially enhance its product quality. New lines for glass injection vials as well as solid plastic dosages, closures and security systems have also been ramped up. Further enhancing Gerresheimer's local production and sales footprint in Emerging Markets is part of the company's regional expansion plans. With that, Gerresheimer is well positioned for being global partner for pharma solutions and platforms.
© S&P Capital IQ 2022
Copier lien
All news about GERRESHEIMER AG
2d ago
06/23
06/23
06/22
06/15